Identification of a nucleotide binding site in HIV-1 integrase

AUTOR(ES)

Drake, Richard R.

FONTE

The National Academy of Sciences

RESUMO

HIV-1 integrase is essential for viral replication and can be inhibited by antiviral nucleotides. Photoaffinity labeling with the 3′-azido-3′-deoxythymidine (AZT) analog 3′,5-diazido-2′,3′-dideoxyuridine 5′-monophosphate (5N3-AZTMP) and proteolytic mapping identified the amino acid 153–167 region of integrase as the site of photocrosslinking. Docking of 5N3-AZTMP revealed the possibility for strong hydrogen bonds between the inhibitor and lysines 156, 159, and 160 of the enzyme. Mutation of these residues reduced photocrosslinking selectively. This report elucidates the binding site of a nucleotide inhibitor of HIV-1 integrase, and possibly a component of the enzyme polynucleotide binding site.

Documentos Relacionados

• Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry
• Identification of the B cell superantigen-binding site of HIV-1 gp120
• Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes
• Inhibitors of HIV-1 replication that inhibit HIV integrase.
• Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis.